Literature DB >> 21864482

Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients.

Chien-Hua Huang1, Min-Shan Tsai, Chiung-Yuan Hsu, Huei-Wen Chen, Tzung-Dau Wang, Wei-Tien Chang, Matthew Huei-Ming Ma, Kuo-Liong Chien, Shyr-Chyr Chen, Wen-Jone Chen.   

Abstract

Early prediction of prognosis is helpful in cardiac arrest patients. Plasma cell-free DNA, which increases rapidly after cell death, is a novel biomarker for the prognosis of critical ill patients. Changes in the plasma cell-free DNA level and its role for the early prognosis of cardiac arrest patients remain unclear. We prospectively enrolled adult out-of-hospital cardiac arrest (OHCA) patients with sustained return of spontaneous circulation. The resuscitation variables were recorded following the Utstein recommendation. The plasma cell-free DNA concentration was determined by quantitative real-time polymerase chain reaction assay of β-globin gene. A total of 42 patients were enrolled for the study. The plasma cell-free DNA level within 2h after cardiac arrest was higher in the non-survival group than the survival-to-discharge group (median level 1659.9 g.e./mL vs. 1121.6g.e./mL, p=0.003 by non-parametric test). The plasma cell-free DNA level at 72 h became no difference between these two groups. The optimal cutoff value of plasma cell-free DNA for predicting survival-to-discharge was 1,170 g.e./mL by ROC curve analysis (area under curve 0.752, p=0.010). A plasma cell-free DNA level higher than 1,170 g.e./mL and was an independent predictor for in-hospital mortality by multiple logistic regression analysis (adjusted odds ratio of 12.35, p=0.023) and was also associated with higher 90 day mortality (p=0.021 by log-rank test). In conclusion, the plasma cell-free DNA level increases during the early post-cardiac arrest phase and can be an early prognostic factor for OHCA patients.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864482     DOI: 10.1016/j.resuscitation.2011.07.039

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  13 in total

1.  Characterization of mitochondrial injury after cardiac arrest (COMICA).

Authors:  Michael W Donnino; Xiaowen Liu; Lars W Andersen; Jon C Rittenberger; Benjamin S Abella; David F Gaieski; Joseph P Ornato; Raúl J Gazmuri; Anne V Grossestreuer; Michael N Cocchi; Antonio Abbate; Amy Uber; John Clore; Mary Anne Peberdy; Clifton W Callaway
Journal:  Resuscitation       Date:  2017-01-23       Impact factor: 5.262

Review 2.  Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies.

Authors:  Kei Hayashida; Ryosuke Takegawa; Muhammad Shoaib; Tomoaki Aoki; Rishabh C Choudhary; Cyrus E Kuschner; Mitsuaki Nishikimi; Santiago J Miyara; Daniel M Rolston; Sara Guevara; Junhwan Kim; Koichiro Shinozaki; Ernesto P Molmenti; Lance B Becker
Journal:  J Transl Med       Date:  2021-05-17       Impact factor: 5.531

3.  Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room.

Authors:  Chia-Te Kung; Sheng-Yuan Hsiao; Tsung-Cheng Tsai; Chih-Min Su; Wen-Neng Chang; Chi-Ren Huang; Hung-Chen Wang; Wei-Che Lin; Hsueh-Wen Chang; Yu-Jun Lin; Ben-Chung Cheng; Ben Yu-Jih Su; Nai-Wen Tsai; Cheng-Hsien Lu
Journal:  J Transl Med       Date:  2012-06-21       Impact factor: 5.531

4.  Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation.

Authors:  Vasudevan Dinakaran; Andiappan Rathinavel; Muthuirulan Pushpanathan; Ramamoorthy Sivakumar; Paramasamy Gunasekaran; Jeyaprakash Rajendhran
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 5.  Prognostic value of circulating DNA levels in critically ill and trauma patients.

Authors:  Edison Moraes Rodrigues Filho; Nilo Ikuta; Daniel Simon; Andrea Pereira Regner
Journal:  Rev Bras Ter Intensiva       Date:  2014 Jul-Sep

6.  Predicting the outcomes for out-of-hospital cardiac arrest patients using multiple biomarkers and suspension microarray assays.

Authors:  Chien-Hua Huang; Min-Shan Tsai; Kuo-Liong Chien; Wei-Tien Chang; Tzung-Dau Wang; Shyr-Chyr Chen; Matthew Huei-Ming Ma; Hsin-Yun Hsu; Wen-Jone Chen
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

7.  Serum proteomics as a strategy to identify novel biomarkers of neurologic recovery after cardiac arrest: a feasibility study.

Authors:  J Gordon Boyd; Laura J Smithson; Daniel Howes; John Muscedere; Michael D Kawaja
Journal:  Intensive Care Med Exp       Date:  2016-05-10

8.  Comet assay in evaluating deoxyribonucleic acid damage after out-of-hospital cardiac arrest.

Authors:  Radka Hazuková; Martina Rezácová; Renata Köhlerová; Tomáš Tomek; Eva Cermáková; Jaromír Kocí; Miloslav Pleskot
Journal:  Anatol J Cardiol       Date:  2017-06-22       Impact factor: 1.596

Review 9.  Circulating Tumor DNA as Biomarkers for Cancer Detection.

Authors:  Xiao Han; Junyun Wang; Yingli Sun
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-04-07       Impact factor: 7.691

10.  Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study.

Authors:  Francisco Arnalich; Maria Constanza Maldifassi; Enrique Ciria; Rosa Codoceo; Jaime Renart; Carmen Fernández-Capitán; Rafael Herruzo; Francisco Garcia-Rio; Eduardo López-Collazo; Carmen Montiel
Journal:  Crit Care       Date:  2013-05-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.